BIOKIN PHARMACEUTICAL
688506298.002.93% ( -9.01 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: BIOKIN PHARMACEUTICAL(688506) the Revenue is 94.59 M (+40.25%);the EBIT is -761.79 M (-33.89%);the EPS is -1.88 (-41.35%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.09B40.25%
----
----
EBIT
-0.76B33.89%
----
----
EPS
-1.8841.35%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf